{
  "Variants Include": [
    {
      "Gene": "SYNJ2",
      "variants": [
        {
          "HGVS": "NM_001146380.1:c.1292G>T",
          "cDNA Change": {
            "transcript": "NM_001146380.1",
            "ref": "G",
            "alt": "T",
            "position": "1292"
          },
          "Protein Change": {
            "ref": "R",
            "alt": "W",
            "position": "431"
          },
          "Description in input context": "R431W"
        }
      ]
    },
    {
      "Gene": "SYNJ1",
      "variants": [
        {
          "HGVS": "NM_001146380.1:c.1292G>T",
          "cDNA Change": {
            "transcript": "NM_001146380.1",
            "ref": "G",
            "alt": "T",
            "position": "1292"
          },
          "Protein Change": {
            "ref": "R",
            "alt": "W",
            "position": "431"
          },
          "Description in input context": "R431W"
        }
      ]
    },
    {
      "Gene": "LRRK2",
      "variants": [
        {
          "HGVS": "NM_181801.2:c.6056G>A",
          "cDNA Change": {
            "transcript": "NM_181801.2",
            "ref": "G",
            "alt": "A",
            "position": "6056"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "S",
            "position": "2019"
          },
          "Description in input context": "G2019S"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0005143"
  },
  "Experiment Method": [
    {
      "Assay Method": "Western Blot",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "HEK293",
        "Description": "HEK293 cells were transfected with wild-type and mutant SYNJ2/SYNJ1/LRRK2 constructs."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_001146380.1:c.1292G>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "SYNJ2 R431W showed 50% reduced protein levels compared to wild-type."
        },
        {
          "Variant": "NM_001146380.1:c.1292G>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "SYNJ1 R431W exhibited 40% reduced protein stability."
        },
        {
          "Variant": "NM_181801.2:c.6056G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "LRRK2 G2019S demonstrated 200% increased kinase activity."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three independent biological replicates were performed."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was analyzed in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type constructs were used as positive controls."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector-transfected cells served as negative controls."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "2"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Student's t-test was used for comparisons."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Protein expression ≥ 80% of wild-type levels.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Protein expression < 50% of wild-type levels.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Immunoprecipitation",
      "Material used": {
        "Material Source": "Patient-derived material",
        "Material Name": "Fibroblasts from Parkinson's patients",
        "Description": "Fibroblasts were collected from patients with LRRK2 G2019S mutations."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_181801.2:c.6056G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "LRRK2 G2019S showed increased phosphorylation of downstream targets."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "No",
        "Description": "N.D."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each immunoprecipitation was repeated twice."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type fibroblasts were used as positive controls."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "IgG control was used as negative controls."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "No",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Phosphorylation levels within ±15% of control.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Phosphorylation levels > 30% of control.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Ubiquitination assay",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "HEK293",
        "Description": "HEK293 cells were co-transfected with ubiquitin and mutant SYNJ2/SYNJ1 constructs."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_001146380.1:c.1292G>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "SYNJ2 R431W showed 30% increased ubiquitination."
        },
        {
          "Variant": "NM_001146380.1:c.1292G>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "SYNJ1 R431W exhibited 25% increased ubiquitination."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Two independent biological replicates were performed."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was analyzed in duplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type constructs were used as positive controls."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Cells without ubiquitin were used as negative controls."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "1"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "ANOVA with post-hoc testing."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Ubiquitination levels ≤ 10% of wild-type.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Ubiquitination levels > 20% of wild-type.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}